Results 151 to 160 of about 44,950 (250)

5.1 IBA Thüringen

, 2022
openaire   +1 more source

The performance of ⁶⁸Ga-DOTA-IBA PET/CT for detecting bone metastases compared with ^99mTc-MDP bone scintigraphy. [PDF]

Sci Rep
Lin X, Zhang N, Wang R, Liu H, Wang W, Xu T, Chen Y.   +6 more
europepmc   +1 more source

Real‐world effectiveness of cenobamate in drug‐resistant and ultra‐refractory epilepsy: A multicenter study

Epilepsia Open, Volume 11, Issue 4, Page 1276-1289, August 2026.
Abstract Objective To evaluate the real‐world effectiveness, safety, and treatment retention of cenobamate (CNB) in patients with drug‐resistant epilepsy (DRE), including ultra‐refractory epilepsy (URE), high seizure burden, and extensive prior treatment history.
Ondřej Strýček, Jana Amlerová, Martin Pail, Jitka Kočvarová, Jana Slonková, Martin Šimčík, Kateřina Stanzelová, Monika Šibalová, Petr Marusič, Milan Brázdil   +9 more
wiley   +1 more source

Caffeine attenuates cisplatin induced microglial reactivity and cognitive dysfunction. [PDF]

Front Mol Neurosci
Oliveros A, Loncar I, Mostafa M, Poleschuk M, Corujo AM, Qin B, Song J, Tischfield MA, Jang MH.   +8 more
europepmc   +1 more source

Radiobiology studies of gold nanoparticle‐enhanced radiosensitization in proton therapy

Medical Physics, Volume 53, Issue 8, August 2026.
Abstract Background Approximately 50%$\%$ of newly diagnosed cancer patients worldwide receive radiotherapy, most commonly with X‐rays. Proton therapy has emerged as a promising alternative, offering complementary advantages over conventional X‐rays due to its highly localized energy deposition at the Bragg peak, thereby reducing radiation exposure to ...
N. Fuster‐Martínez, D. H. Saucedo‐Cuberes, M. C. Jiménez‐Ramos, D. Esperante, J. M. Espino, J. Fuster, J. F. Belén‐Aguilar, L. González‐López, P. Huertas, S. Jimeno, I. Mingarro, D. Pascual, D. Suárez‐García, M. J. García‐Murria   +13 more
wiley   +1 more source

Combined Use of Ibalizumab and Lenacapavir for the Treatment of Multidrug-resistant HIV-1: A Case Series. [PDF]

Clin Infect Dis
Rolle C, Achhra A, Harbison C, Finkel D, Lucasti C, Martorell C, McClendon T, Slim J.   +7 more
europepmc   +1 more source

Towards automated dose‐guided patient positioning at clinical timescale in head‐and‐neck cancer proton radiotherapy

Medical Physics, Volume 53, Issue 8, August 2026.
Abstract Background In intensity modulated proton therapy (IMPT) accurate patient positioning prior to treatment delivery is important to ensure that the prescribed dose is delivered as intended. Typically, in‐room 3D imaging is utilized to position the patient based on anatomical features, which can be challenging due to interfractional anatomical ...
Femke Oosterhof, Gabriel Guterres Marmitt, Alexander M. Kamerbeek, Jeffrey Free, Gerolf Meulman, Zohreh Shahpouri, Pietro Pisciotta, Johannes A. Langendijk, Stefan Both   +8 more
wiley   +1 more source

Type 2 Diabetes Promotes the Microglial Pyroptosis by Activating NLRP3 Inflammasome to Impede Remyelination After Spinal Cord Injury. [PDF]

Research (Wash D C)
Xu J, Fang L, Wei T, Cai S, Chen R, Wang B, Nie S, Wu Y, Yan F, Shao J, Wu W, Zhan Y, Xu K, Xiao J, Wu Y.   +14 more
europepmc   +1 more source

A comparison of relative stopping power derived by fast kV‐switching dual‐energy CT, single‐energy CT, and proton CT in phantom and tissue

Medical Physics, Volume 53, Issue 8, August 2026.
Abstract Background The accuracy of relative stopping power (RSP) is a critical aspect for safe treatment planning in proton therapy. Dual‐energy CT (DECT) has the ability to estimate RSP more accurately than conventional single‐energy CT (SECT) due to its improved material separation. RSP accuracy is commonly determined in homogeneous phantom material
Hazel Wang, Yanling Qu, Yang Li, George Dedes, Maggie Stauffer, Robert Johnson, Paul Deak, Mark Pankuch   +7 more
wiley   +1 more source

HIV-1 Non Group-M Phenotypic Susceptibility to Ibalizumab. [PDF]

J Med Virol
Poisson L, Hingrat QL, Lermechain F, Tombette F, Jullien H, Plantier JC, Alessandri-Gradt E.   +6 more
europepmc   +1 more source